P2‐037: Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer’s disease neuroimaging initiative

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/152628/1/alzjjalz2008051118.pd

P2‐037: Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer’s disease neuroimaging initiative

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/152628/1/alzjjalz2008051118.pd

P2‐037: Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer’s disease neuroimaging initiative

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/152628/1/alzjjalz2008051118.pd

IC‐P1‐036: Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer’s disease neuroimaging initiative

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/153197/1/alzjjalz200805047.pd

P1‐416: Use of an Alzheimer’s Disease‐Related Hypometabolic Convergence Index to Predict Progression from Mild Cognitive Impairment to Alzheimer’s Dementia

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/152809/1/alzjjalz201005971.pd

African-American TOMM40'523-APOE haplotypes are admixture of West African and Caucasian alleles

Background: Several studies have demonstrated a lower apolipoprotein E4 (APOE e4) allele frequency in African-Americans, but yet an increased age-related prevalence of AD. An algorithm for prevention clinical trials incorporating TOMM40'523 (Translocase of Outer Mitochondria Membrane) and APOE depends on accurate TOMM40'523-APOE haplotypes. Methods: We have compared the APOE and TOMM40'523 phased haplotype frequencies of a 9.5 kb TOMM40/APOE genomic region in West African, Caucasian, and African-American cohorts. Results: African-American haplotype frequency scans of poly-T lengths connected in phase with either APOE e4 or APOE e3 differ from both West Africans and Caucasians and represent admixture of several distinct West African and Caucasian haplotypes. A new West African TOMM40'523 haplotype, with APOE e4 connected to a short TOMM40'523 allele, is observed in African-Americans but not Caucasians. Conclusion: These data have therapeutic implications for the age of onset risk algorithm estimates and the design of a prevention trial for African-Americans or other mixed ethnic populations